| Role of hydrogen peroxide in the aetiology of Alzheimer’s disease: implications for treatment NGN Milton Drugs & aging 21, 81-100, 2004 | 180 | 2004 |
| Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome. AJ Holland, J Treasure, P Coskeran, J Dallow, N Milton, E Hillhouse International journal of obesity and related metabolic disorders: journal of …, 1993 | 172 | 1993 |
| Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide NGN Milton Neuroscience Letters 332 (2), 127-130, 2002 | 164 | 2002 |
| The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy EW Hillhouse, D Grammatopoulos, NG Milton, HW Quartero The Journal of Clinical Endocrinology & Metabolism 76 (3), 736-741, 1993 | 149 | 1993 |
| Amyloid-beta binds catalase with high affinity and inhibits hydrogen peroxide breakdown. NG Milton Biochemical Journal 344 (Pt 2), 293, 1999 | 88 | 1999 |
| Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer’s amyloid-β peptide NGN Milton Neurotoxicology 22 (6), 767-774, 2001 | 81 | 2001 |
| Effect of noradrenaline and γ-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro EW Hillhouse, NGN Milton Journal of endocrinology 122 (3), 719-723, 1989 | 81 | 1989 |
| The human myometrial CRH receptor: G proteins and second messengers D Grammatopoulos, NGN Milton, EW Hillhouse Molecular and cellular endocrinology 99 (2), 245-250, 1994 | 71 | 1994 |
| Phosphorylation of amyloid-β at the serine 26 residue by human cdc2 kinase NGN Milton Neuroreport 12 (17), 3839-3844, 2001 | 69 | 2001 |
| Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate … DJ Byrne, IA Jagroop, HE Montgomery, M Thomas, DP Mikhailidis, ... Journal of clinical pathology 55 (4), 280-285, 2002 | 61 | 2002 |
| Cholesterol in Alzheimer’s disease and other amyloidogenic disorders JR Harris, NGN Milton Cholesterol Binding and Cholesterol Transport Proteins: Structure and …, 2010 | 59 | 2010 |
| Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro EW Hillhouse, NGN Milton Journal of endocrinology 122 (3), 713-718, 1989 | 59 | 1989 |
| Identification of amyloid-β binding sites using an antisense peptide approach NGN Milton, NP Mayor, J Rawlinson Neuroreport 12 (11), 2561-2566, 2001 | 46 | 2001 |
| Kisspeptin Prevention of Amyloid-β Peptide Neurotoxicity in Vitro NGN Milton, A Chilumuri, E Rocha-Ferreira, AN Nercessian, M Ashioti ACS chemical neuroscience 3 (9), 706-719, 2012 | 44 | 2012 |
| The Neuronal Nicotinic Acetylcholine Receptor α2 Subunit Gene Promoter Is Activated by the Brn-3b POU Family Transcription Factor and Not by Brn-3a or Brn-3c (∗) NGN Milton, A Bessis, JP Changeux, DS Latchman Journal of Biological Chemistry 270 (25), 15143-15147, 1995 | 44 | 1995 |
| Homocysteine inhibits hydrogen peroxide breakdown by catalase NGN Milton Open Enzym Inhib J 1 (1), 34-41, 2008 | 36 | 2008 |
| Differential regulation of neuronal nicotinic acetylcholine receptor subunit gene promoters by Brn-3 POU family transcription factors NGN Milton, A Bessis, JP Changeux, DS Latchman Biochemical Journal 317 (2), 419-423, 1996 | 33 | 1996 |
| Activation of the hypothalamo-pituitary-adrenocortical axis in the conscious rabbit by the pyrogen polyinosinic: polycytidylic acid is dependent on corticotrophin-releasing … NGN Milton, EW Hillhouse, AS Milton Journal of endocrinology 135 (1), 69-75, 1992 | 30 | 1992 |
| Polymorphism of amyloid-β fibrils and its effects on human erythrocyte catalase binding NGN Milton, JR Harris Micron 40 (8), 800-810, 2009 | 29 | 2009 |
| Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide NGN Milton, JR Harris Micron 44, 246-253, 2013 | 28 | 2013 |
